As Chief Scientific Officer and President, Research & Development, for Pfizer, Inc., Chris Boshoff leads the company’s research and development strategy and execution in all Therapeutic Areas, including Inflammation & Immunology, Internal Medicines, Oncology and Vaccines, and is responsible for Pfizer’s Medical Affairs, Safety, Global ...

Nov 20, 2024 · Boshoff, who most recently served as Chief Oncology Officer and Executive Vice President, will succeed Dr. Mikael Dolsten whose departure from Pfizer was announced earlier this year.

We’re proud to announce that after a comprehensive search, Pfizer’s current Chief Oncology Officer and Executive Vice President, Dr. Chris Boshoff, M.D., Ph.D., has been appointed as Pfizer’s Chief Scientific Officer and President, Research & …

Nov 20, 2024 · (Reuters) -Pfizer said on Wednesday it has named company veteran and oncology head Chris Boshoff as its chief of research and development, as the drugmaker faces pressure from investors to...

Nov 20, 2024 · Pfizer said on Wednesday it has named company veteran and oncology head Chris Boshoff as its chief of research and development, as the drugmaker faces pressure from investors to produce...

Nov 20, 2024 · Pfizer on Wednesday said it will promote Chris Boshoff to chief scientific officer and president of research and development as the giant drugmaker struggles to win back the faith of investors. Boshoff will assume his new post on Jan. 1, succeeding Mikael Dolsten, who oversaw research at Pfizer for 15 years.

May 29, 2024 · As a member of Pfizer’s executive leadership team, Chris Boshoff, Chief Oncology Officer, Executive Vice President, is responsible for further advancing Pfizer’s Oncology portfolio.

Dec 18, 2024 · Pfizer has announced the appointment of Chris Boshoff as Chief Scientific Officer and President of Research & Development, effective January 1, 2025. Boshoff, who previously served as Chief Oncology Officer and Executive Vice President, will succeed Dr. Mikael Dolsten.

Mar 6, 2025 · Pfizer has named chief oncology officer Dr Chris Boshoff to the new role of chief of R&D, as the company faces down criticism of its recent efforts to develop and build its pipeline.